Peter Braunhofer is a highly experienced Market Access leader with a strong background in R&D. He has held leading positions at both payers and pharmaceutical companies, making him highly versatile and skilled at navigating the mechanics of P&R systems across Europe. He is an expert in developing value strategies, HTA/value dossiers, supporting local submissions, and leading price or tariff negotiations. He has a comprehensive understanding of payers and alternative contracting, and he efficiently executes market access road-maps.

Peter Braunhofer studied Master of Health Business Administration (MHBA), Health Economics, Master at Friedrich Alexander University of Erlangen-Nürnberg, Master of Science Biology, Embryology, Zoology, Molecular Genetics, Master at Friedrich-Alexander-Universität Erlangen-Nürnberg, and University Professional of Advanced Studies in Pharmaceutical Medicine, Pharmaceutical Medicine at Universität Basel.

Peter Braunhofer has held several key positions including Market Access and Policy Director Alpine and The Netherlands at Alexion Pharmaceuticals, Inc., Senior Director Value & Access Switzerland/Europe at Healthecon AG, Global Health Economics & Market Access Director at Vifor Pharma, Senior Access Manager at Pfizer, Head Managed Care Pharma at Helsana Versicherungen AG, and International Regulatory Affairs Associate at Janssen, Pharmaceutical Companies of Johnson and Johnson.